Terveystalo stock
Price history
−33.59% over the period1 year: from €9.14 (November 17, 2025) to €6.07 (November 17, 2026), −33.59%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | €6.07 |
| October 30, 2026 | €6.04 |
| September 30, 2026 | €7.44 |
| August 31, 2026 | €7.62 |
| July 31, 2026 | €7.57 |
| June 30, 2026 | €7.66 |
| May 29, 2026 | €8.09 |
| April 30, 2026 | €7.80 |
| March 31, 2026 | €8.65 |
| February 27, 2026 | €9.32 |
| January 30, 2026 | €10.14 |
| December 30, 2025 | €9.78 |
| November 28, 2025 | €9.38 |
| November 17, 2025 | €9.14 |
At a glance
The company
Provides occupational healthcare services including general practice, specialist medical care, diagnostics, dental and digital health services across Finland, Sweden and Estonia
Latest results
Quarter to September 30, 2026 · EPS €0.07 (estimate €0.11)
TickerLandia's take on Terveystalo
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 8.3 vs a median of 23 over its last 8 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 14 vs 33 (−59%) in a group of 10.
- Strong point: Dividend (81/100 in its group). Weak point: Market momentum (5/100).
- “Dividend traps” (Finland): No. 1 of 4.
- “Below historical valuation” (Finland): No. 2 of 3.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−41.55% from the 52-week high
Analysts · 3 analysts
Average target€7.17+17.68% vs. price
Buy 1 · Hold 1 · Sell 1
TickerLandia Fingerprint: Terveystalo
Compared with similar companies: very weak momentum, very low growth, and very low earnings stability.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricelow20
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 13.5 25 Forward P/E 9.27 8 EV/EBITDA 9.27 29 Price/sales 0.65 18 Price/book 1.44 21 Profitabilitylow26
How much it earns on revenue and capital.
Metric Value Position in group ROA 4.5% 24 ROE 10.4% 31 Net margin 4.8% 18 Gross margin 27.7% 34 Operating margin 8.9% 24 Earnings stabilityvery low11
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.7% 13 Loss-making yearscounts in reverse: lower means more earnings stability 1 of 5 annual reports 8 Growthvery low6
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +0.52% 8 Earnings growth (year over year) −68.70% 8 Revenue growth (year over year) −6.20% 3 Financial strengthlow37
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 6.82 55 Current ratio 0.61 8 Net debt/EBITDAcounts in reverse: lower means more financial strength 2.64 50 Debt/equitycounts in reverse: lower means more financial strength 1.34 36 Dividendvery high81
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 9 years 50 Payout ratiopays out more than its earnings 213.3% 97 Dividend yield 10.5% 97 Market momentumvery weak5
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −33.37% 5 Distance from 200-day average −22.75% 5 Riskhigh72
How much the price swings.
Metric Value Position in group Volatility (60 days) 28.4% 55 Maximum drawdown (12 months) 42.4% 90
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Terveystalo is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Terveystalo's P/E today is 8.32, below the median of its last 8 fiscal years (22.7; between 13.4 and 148.3 from 2017 to 2025). Terveystalo's P/E (trailing 12 months): 13.5, −59% against the median of a group of 10 similar companies (32.9).
Compared with 10 similar companies
| Metric | Terveystalo | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 13.5 | Low | |
| Forward P/E | 9.27 | Low | |
| Operating margin | 8.9% | Middle | |
| ROE | 10.4% | Middle | |
| Debt/equity | 1.34 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Terveystalo. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€262.9M
Latest quarter · Q3 2026
Net income
€5.5M
Latest quarter · Q3 2026
Quarterly net margin
2.1%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- €772.27M
- P/E
- 13.5
- EPS
- €0.45
- Volume
- 138.63K
- Daily trading
- €1.46M
- Dividend yield
- 15.76%
- Last ex-dividend on October 7, 2026
How Terveystalo is changing
All resultsRevenue grew 5.3% a year on average over the last 5 years
Operating margin rose from 5.3% to 11.5%
Profitable in 4 of 5 fiscal years
Returns
Terveystalo returns with dividends
€1,000 invested in Terveystalo 5 years ago, on November 17, 2021, would be worth €695 today with dividends reinvested: −30.46% in total, −7.01% per year. On price alone it would be €529 (−47.13%).
| Period | Terveystalo | €1,000 becomes |
|---|---|---|
| 1 month | −9.54% | €905 |
| 6 months | −22.42% | €776 |
| Year to date | −37.93% | €621 |
| 1 year | −24.89% | €751 |
| 3 years | +4.69% | €1,047 |
| 5 years | −30.46% | €695 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Terveystalo: technical analysis
Terveystalo is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 51.5% below its all-time closing high (€12.56, September 6, 2021).
- Trend
- Downward
- RSI (14 sessions)
- 34
- Between 30 and 70
- vs 200-session average
- −22.75%
Support and resistance
Price areas where Terveystalo has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€7.61+24.90%3 touches, last on September 16, 2026
- Resistance€7.31+20.03%2 touches, last on June 18, 2026
- Resistance€6.30+3.45%2 touches, last on November 9, 2026
- Last price€6.09
- No support below: the price is near the lows of the year
Volatility and risk
- Volatility (60 sessions, annualised)
- 28.4%
- Largest fall in the last year
- −42.36%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Terveystalo: seasonality
Average monthly price change over 9 years
Over the last 9 years, the strongest month for Terveystalo has been January: +6.36% on average, positive in 8 years out of 9. The weakest has been October: −6.42% on average, positive in 3 years out of 9. November, the current month, has been positive in 5 years out of 9 (+2.48% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +6.36% | +5.18% | 8 of 9 |
| February | −1.87% | −2.73% | 4 of 9 |
| March | −2.51% | +0.53% | 5 of 9 |
| April | +3.57% | +0.51% | 5 of 9 |
| May | +2.06% | +1.64% | 5 of 9 |
| June | −2.78% | −3.26% | 2 of 9 |
| July | −1.80% | −2.51% | 3 of 9 |
| August | +0.71% | −1.67% | 4 of 9 |
| September | −4.02% | −3.75% | 1 of 9 |
| October | −6.42% | −5.57% | 3 of 9 |
| November | +2.48% | +0.54% | 5 of 9 |
| December | +2.36% | +4.26% | 6 of 9 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Terveystalo and its competitors
Occupational healthcare, general practice and dental care delivered under the Terveystalo name form the core of the business, alongside imaging and laboratory tests, child welfare services and outpatient surgery. Beyond these, the group sells healthcare outsourcing and staffing, remote and digital services, therapy and rehabilitation, and addiction prevention. Its customers include private individuals and families, corporate and consumer clients, insurance companies and public sector bodies, and it operates in Finland, Sweden and Estonia.
- Headquarters
- Helsinki, Finland
- Employees
- 8,111
- Founded
- 2001
- Chief executive
- Ville Iho
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| TerveystaloTTALO | $848.65M | 8.9% | 13.5 | −22.42% |
| Spire Healthcare GroupSPI | $1.31B | 6.2% | — | +8.79% |
| MedicoverMCOV.B | $3.88B | 7.4% | 38.5 | +28.68% |
| Fresenius Medical CareFME | $11.77B | 10.3% | 12.1 | +6.69% |
| FreseniusFRE | $29.53B | 9.8% | 17.2 | +38.53% |
| Mouwasat Medical Services4002 | $3.13B | 25.5% | 37.0 | −9.80% |
Same industry or related industries, similar size. Compare Terveystalo with its competitors · Full profile
